The only "deflating" was the ACB of the newest.... Limited edition insider and US bound appetizer at 42.5 cents!
Surprising that they chose to "file" on the Friday afternoon of a Canadian long weekend?
Geez, I'll bet a lot of people saw that cross the tape!
If only such careful precision was applied to the per protocol patient population.... well, maybe the new Tiger will roar? Someone just put $180,000 down on the tiger at 62-1... I would gave gone 99-1 based on pure optics, but we do have those dang FDA approvals and phase IV Tigris with a 2 to 1 ratio in favor of us so... 62-1 odds feels more fitting.
Best,
Gadge